Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 47, Issue 4 (Apr 2009)

Issues

Stromal cell-derived factor-1 but not its receptor, CXCR4, gene variants increase susceptibility and pathological development of hepatocellular carcinoma

Chi-Chung Chang
  • Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan
/ Shu-Chen Chen
  • Department of Nursing, Central Taiwan University of Science and Technology and Institute of Medicine, School of Nursing, Chung Shan Medical University, Taichung, Taiwan
/ Yi-Hsien Hsieh
  • Center for Molecular Medicine, China Medical University Hospital, Taichung, Taiwan
/ Yi-Chen Chen
  • School of Nutrition, Chung Shan Medical University, Taichung, Taiwan
/ Tzy-Yen Chen
  • Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
/ Yin-Hung Chu
  • Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan
/ Hui-Jen Ma
  • Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan
/ Ming-Chih Chou
  • Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan
/ Hsiu-Ting Tsai
  • School of Nursing, Chung Shan Medical University, Taichung, Taiwan
/ Shun-Fa Yang
  • Institute of Medicine, Chung Shan Medical University and Department of Medical Research, Department of Clinical Laboratory, Chung Shan Medical University Hospital, Taichung, Taiwan

Abstract

Background: Hepatocellular carcinoma (HCC) is one of the most frequent malignant neoplasms worldwide. Genetic polymorphism has been reported as a predictive factor related to a higher risk for HCC. Because the stromal cell-derived factor-1 (SDF-1) and its receptor, CXCR4, have been reported to play important roles in tumor cell proliferation, angiogenesis, and metastasis of HCC, the aim of this study was to estimate the relationship between SDF-1 and CXCR4 gene variants to HCC risk and clinicopathological status.

Methods: Polymerase chain reaction-restriction fragment length polymorphism was used to measure SDF-1 (rs1801157) and CXCR4 (rs2228014) gene polymorphisms in 311 healthy controls and 102 patients with HCC.

Results: Compared to controls, individuals with at least one A allele had a higher risk of 1.57-fold (95% CI: 1.00–2.47) to induce HCC and had a risk of 2.81-fold (95% CI: 1.04–7.58) to develop a status of stage III or stage IV disease, after being adjusted for other confounders. However, there was no significant association between CXCR4 gene polymorphism and either HCC risk or pathological status. Additionally, both gene polymorphisms were not associated with the serum expression of liver-related clinical pathological markers.

Conclusions: SDF-1–3′A gene polymorphism could be considered as a factor related to an increased susceptibility to the risk and pathological development of HCC.

Clin Chem Lab Med 2009;47:412–8.

Keywords: CXCR4; hepatocellular carcinoma (HCC); single nucleotide polymorphism (SNP); stromal cell-derived factor-1 (SDF-1)

About the article

Corresponding authors: Shun-Fa Yang, PhD, and Hsiu-Ting Tsai, PhD, Institute of Medicine, Chung Shan Medical University, 110, Section 1, Chien-Kuo N. Road, Taichung, Taiwan, ROC Phone: +886-4-24739595 #34253, Fax +886-4-24723229, (S.-F. Yang), (H.-T. Tsai)


Received: 2008-09-23

Accepted: 2009-01-05

Published in Print: 2009-04-01


Citation Information: Clinical Chemistry and Laboratory Medicine, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2009.092.

Export Citation

©2009 by Walter de Gruyter Berlin New York. Copyright Clearance Center

Comments (0)

Please log in or register to comment.
Log in